Mary C. Smith Fawzi, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Depression | 13 | 2022 | 7766 | 1.300 |
Why?
|
| Growth Disorders | 4 | 2020 | 645 | 1.040 |
Why?
|
| HIV Infections | 19 | 2022 | 16718 | 1.000 |
Why?
|
| Psychotherapy, Group | 2 | 2020 | 406 | 0.890 |
Why?
|
| Tanzania | 12 | 2022 | 1346 | 0.790 |
Why?
|
| Caregivers | 4 | 2015 | 2094 | 0.740 |
Why?
|
| Social Support | 6 | 2020 | 2118 | 0.740 |
Why?
|
| Haiti | 13 | 2021 | 553 | 0.730 |
Why?
|
| Sexual Partners | 5 | 2021 | 730 | 0.680 |
Why?
|
| Spouse Abuse | 2 | 2021 | 178 | 0.680 |
Why?
|
| Child Nutrition Disorders | 2 | 2020 | 149 | 0.650 |
Why?
|
| Mental Health | 8 | 2021 | 3019 | 0.630 |
Why?
|
| Perinatal Care | 1 | 2020 | 227 | 0.610 |
Why?
|
| Child Development | 3 | 2018 | 2223 | 0.590 |
Why?
|
| Anxiety | 6 | 2021 | 4297 | 0.580 |
Why?
|
| Rural Population | 7 | 2021 | 2210 | 0.540 |
Why?
|
| Internal-External Control | 2 | 2015 | 363 | 0.540 |
Why?
|
| Depression, Postpartum | 2 | 2019 | 340 | 0.530 |
Why?
|
| Adaptation, Psychological | 4 | 2015 | 2576 | 0.510 |
Why?
|
| Risk-Taking | 1 | 2020 | 986 | 0.500 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 547 | 0.500 |
Why?
|
| Adolescent Behavior | 2 | 2015 | 1151 | 0.470 |
Why?
|
| Life Change Events | 1 | 2018 | 938 | 0.450 |
Why?
|
| HIV | 1 | 2020 | 1604 | 0.440 |
Why?
|
| Anti-Retroviral Agents | 3 | 2020 | 1715 | 0.440 |
Why?
|
| Child of Impaired Parents | 1 | 2016 | 455 | 0.440 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2022 | 2026 | 0.440 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2014 | 347 | 0.410 |
Why?
|
| Self Disclosure | 1 | 2013 | 251 | 0.410 |
Why?
|
| Socioeconomic Factors | 10 | 2020 | 7785 | 0.400 |
Why?
|
| Students | 2 | 2018 | 1654 | 0.400 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2016 | 1873 | 0.380 |
Why?
|
| Women's Rights | 1 | 2011 | 69 | 0.380 |
Why?
|
| Suicidal Ideation | 1 | 2019 | 1248 | 0.370 |
Why?
|
| Water Supply | 1 | 2011 | 214 | 0.370 |
Why?
|
| Developmental Disabilities | 1 | 2018 | 1456 | 0.350 |
Why?
|
| Rwanda | 5 | 2020 | 703 | 0.340 |
Why?
|
| Human Rights | 1 | 2011 | 307 | 0.330 |
Why?
|
| HIV Seropositivity | 2 | 2013 | 971 | 0.330 |
Why?
|
| Malnutrition | 1 | 2014 | 625 | 0.310 |
Why?
|
| Health Priorities | 1 | 2011 | 380 | 0.310 |
Why?
|
| Prevalence | 9 | 2021 | 15226 | 0.300 |
Why?
|
| Nutritional Status | 2 | 2019 | 1609 | 0.300 |
Why?
|
| Family | 4 | 2015 | 3147 | 0.300 |
Why?
|
| Health Services Accessibility | 8 | 2020 | 5137 | 0.290 |
Why?
|
| Cross-Sectional Studies | 12 | 2021 | 25043 | 0.290 |
Why?
|
| Students, Nursing | 1 | 2006 | 45 | 0.280 |
Why?
|
| Stress Disorders, Post-Traumatic | 4 | 2018 | 4266 | 0.280 |
Why?
|
| Adolescent | 21 | 2021 | 85781 | 0.270 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2018 | 2408 | 0.270 |
Why?
|
| Emergencies | 1 | 2012 | 1170 | 0.260 |
Why?
|
| Counseling | 2 | 2013 | 1523 | 0.260 |
Why?
|
| Medication Adherence | 1 | 2016 | 2063 | 0.250 |
Why?
|
| Refugees | 1 | 2012 | 511 | 0.250 |
Why?
|
| Rural Health | 1 | 2006 | 305 | 0.240 |
Why?
|
| Rape | 1 | 2005 | 133 | 0.240 |
Why?
|
| Tuberculosis | 4 | 2023 | 1912 | 0.240 |
Why?
|
| Anti-HIV Agents | 3 | 2016 | 4256 | 0.240 |
Why?
|
| Female | 42 | 2022 | 380194 | 0.230 |
Why?
|
| Depressive Disorder | 6 | 2021 | 3748 | 0.230 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 4 | 2005 | 912 | 0.220 |
Why?
|
| Quality of Life | 5 | 2021 | 12804 | 0.220 |
Why?
|
| Chlamydia Infections | 1 | 2006 | 365 | 0.210 |
Why?
|
| Depressive Disorder, Major | 2 | 2017 | 4644 | 0.210 |
Why?
|
| Cognition | 2 | 2016 | 6770 | 0.210 |
Why?
|
| Young Adult | 11 | 2021 | 56430 | 0.200 |
Why?
|
| Gonorrhea | 1 | 2006 | 335 | 0.200 |
Why?
|
| Psychology | 2 | 2016 | 356 | 0.200 |
Why?
|
| Women's Health | 1 | 2011 | 2034 | 0.200 |
Why?
|
| Poverty | 5 | 2021 | 2660 | 0.200 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2005 | 624 | 0.190 |
Why?
|
| Infectious Disease Transmission, Vertical | 3 | 2022 | 1320 | 0.190 |
Why?
|
| Rural Health Services | 1 | 2005 | 379 | 0.190 |
Why?
|
| Infant | 9 | 2020 | 35136 | 0.190 |
Why?
|
| United Nations | 2 | 2011 | 165 | 0.190 |
Why?
|
| Parents | 2 | 2015 | 3407 | 0.190 |
Why?
|
| Child, Preschool | 10 | 2020 | 41006 | 0.180 |
Why?
|
| Developing Countries | 5 | 2016 | 2815 | 0.180 |
Why?
|
| Humans | 52 | 2023 | 744343 | 0.180 |
Why?
|
| Africa South of the Sahara | 2 | 2019 | 724 | 0.170 |
Why?
|
| Adult | 28 | 2022 | 214055 | 0.170 |
Why?
|
| Mobile Health Units | 1 | 2020 | 80 | 0.170 |
Why?
|
| Male | 29 | 2021 | 350118 | 0.170 |
Why?
|
| Vitamins | 1 | 2007 | 1622 | 0.160 |
Why?
|
| Mental Disorders | 3 | 2017 | 6600 | 0.160 |
Why?
|
| Educational Status | 2 | 2016 | 2540 | 0.160 |
Why?
|
| Social Stigma | 2 | 2016 | 701 | 0.150 |
Why?
|
| Mycobacterium tuberculosis | 3 | 2005 | 1832 | 0.150 |
Why?
|
| Psychological Tests | 1 | 2020 | 651 | 0.150 |
Why?
|
| Cross Infection | 1 | 2006 | 1416 | 0.150 |
Why?
|
| Residence Characteristics | 3 | 2016 | 2050 | 0.140 |
Why?
|
| Pregnancy | 9 | 2022 | 29144 | 0.140 |
Why?
|
| Risk Factors | 11 | 2021 | 72290 | 0.140 |
Why?
|
| Demography | 2 | 2020 | 1656 | 0.140 |
Why?
|
| Psychological Techniques | 1 | 2016 | 45 | 0.140 |
Why?
|
| Policy | 1 | 2020 | 508 | 0.130 |
Why?
|
| Earthquakes | 1 | 2018 | 179 | 0.130 |
Why?
|
| Peru | 4 | 2006 | 881 | 0.130 |
Why?
|
| Leiomyoma | 1 | 2021 | 730 | 0.130 |
Why?
|
| Personality Inventory | 2 | 1998 | 1030 | 0.130 |
Why?
|
| Community-Based Participatory Research | 1 | 2016 | 214 | 0.120 |
Why?
|
| Dietary Supplements | 1 | 2007 | 3297 | 0.120 |
Why?
|
| Multivariate Analysis | 4 | 2014 | 12245 | 0.120 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2016 | 264 | 0.120 |
Why?
|
| Prisoners | 1 | 1997 | 297 | 0.120 |
Why?
|
| School Health Services | 1 | 2017 | 375 | 0.110 |
Why?
|
| Students, Medical | 1 | 2006 | 1862 | 0.110 |
Why?
|
| Schools | 2 | 2018 | 1433 | 0.110 |
Why?
|
| Eritrea | 1 | 2012 | 4 | 0.110 |
Why?
|
| Interviews as Topic | 1 | 2019 | 2539 | 0.110 |
Why?
|
| Child | 10 | 2020 | 77709 | 0.110 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2017 | 2559 | 0.110 |
Why?
|
| Middle Aged | 17 | 2021 | 213383 | 0.100 |
Why?
|
| Sexual Behavior | 2 | 2020 | 2057 | 0.100 |
Why?
|
| Occupations | 2 | 2005 | 517 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 3923 | 0.100 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2016 | 2232 | 0.100 |
Why?
|
| Child, Orphaned | 1 | 2012 | 55 | 0.100 |
Why?
|
| Uterine Neoplasms | 1 | 2021 | 1513 | 0.100 |
Why?
|
| Sanitation | 1 | 2011 | 93 | 0.100 |
Why?
|
| Uganda | 1 | 2016 | 1243 | 0.100 |
Why?
|
| Politics | 2 | 1998 | 791 | 0.100 |
Why?
|
| Age Factors | 4 | 2019 | 18370 | 0.100 |
Why?
|
| Healthy People Programs | 1 | 2011 | 53 | 0.100 |
Why?
|
| Mothers | 2 | 2019 | 2165 | 0.100 |
Why?
|
| Alcoholism | 1 | 2021 | 1906 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 39050 | 0.090 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 687 | 0.090 |
Why?
|
| Consumer Advocacy | 1 | 2011 | 81 | 0.090 |
Why?
|
| Self-Help Groups | 1 | 2012 | 190 | 0.090 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2017 | 6038 | 0.090 |
Why?
|
| Prospective Studies | 6 | 2017 | 53288 | 0.090 |
Why?
|
| Anxiety Disorders | 1 | 2021 | 2690 | 0.090 |
Why?
|
| Ethiopia | 1 | 2012 | 495 | 0.090 |
Why?
|
| Cost of Illness | 2 | 2017 | 1859 | 0.090 |
Why?
|
| Pilot Projects | 4 | 2017 | 8324 | 0.090 |
Why?
|
| HIV-1 | 1 | 2007 | 6939 | 0.090 |
Why?
|
| Teaching | 1 | 2017 | 1174 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2017 | 3022 | 0.080 |
Why?
|
| Health Surveys | 2 | 2016 | 4037 | 0.080 |
Why?
|
| Health Status | 2 | 2019 | 4034 | 0.080 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 643 | 0.080 |
Why?
|
| Chronic Disease | 2 | 2014 | 9146 | 0.080 |
Why?
|
| Maternal Mortality | 1 | 2011 | 310 | 0.080 |
Why?
|
| Sex Factors | 2 | 2019 | 10397 | 0.080 |
Why?
|
| Income | 1 | 2016 | 1913 | 0.070 |
Why?
|
| Blood Specimen Collection | 1 | 2008 | 246 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 1 | 2012 | 1677 | 0.070 |
Why?
|
| Antibiotics, Antitubercular | 2 | 2004 | 104 | 0.070 |
Why?
|
| Mass Screening | 2 | 2023 | 5255 | 0.070 |
Why?
|
| Antitubercular Agents | 2 | 2004 | 1320 | 0.070 |
Why?
|
| Goals | 1 | 2011 | 706 | 0.070 |
Why?
|
| Algorithms | 1 | 2006 | 13881 | 0.070 |
Why?
|
| Parent-Child Relations | 1 | 2010 | 747 | 0.060 |
Why?
|
| India | 1 | 2011 | 2197 | 0.060 |
Why?
|
| Health Education | 1 | 2012 | 1056 | 0.060 |
Why?
|
| Social Class | 2 | 2011 | 1999 | 0.060 |
Why?
|
| Infant, Newborn | 4 | 2016 | 25625 | 0.060 |
Why?
|
| Checklist | 1 | 2012 | 833 | 0.060 |
Why?
|
| Health Services | 1 | 2010 | 758 | 0.060 |
Why?
|
| Child Health Services | 1 | 2010 | 667 | 0.060 |
Why?
|
| International Cooperation | 1 | 2011 | 1420 | 0.060 |
Why?
|
| Psychoses, Substance-Induced | 1 | 2004 | 96 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2017 | 10252 | 0.060 |
Why?
|
| Cycloserine | 1 | 2004 | 113 | 0.060 |
Why?
|
| Primary Health Care | 1 | 2020 | 4558 | 0.060 |
Why?
|
| Lesotho | 1 | 2023 | 70 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2016 | 9849 | 0.060 |
Why?
|
| Isoniazid | 1 | 2005 | 274 | 0.060 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2014 | 810 | 0.060 |
Why?
|
| Substance-Related Disorders | 1 | 2019 | 4258 | 0.060 |
Why?
|
| Rifampin | 1 | 2005 | 315 | 0.060 |
Why?
|
| Program Evaluation | 1 | 2011 | 2488 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 3610 | 0.050 |
Why?
|
| Delivery of Health Care | 2 | 2014 | 5319 | 0.050 |
Why?
|
| Risk | 1 | 2015 | 9687 | 0.050 |
Why?
|
| Health Policy | 2 | 2014 | 2661 | 0.050 |
Why?
|
| Linear Models | 1 | 2012 | 5952 | 0.050 |
Why?
|
| AIDS Serodiagnosis | 1 | 2001 | 184 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2017 | 63114 | 0.040 |
Why?
|
| Vietnam | 2 | 1998 | 408 | 0.040 |
Why?
|
| Boston | 2 | 2006 | 9313 | 0.040 |
Why?
|
| Mexico | 1 | 2021 | 690 | 0.040 |
Why?
|
| Infection Control | 1 | 2006 | 966 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2005 | 1877 | 0.040 |
Why?
|
| Health Promotion | 1 | 2011 | 2205 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2006 | 21746 | 0.040 |
Why?
|
| Torture | 1 | 1998 | 53 | 0.040 |
Why?
|
| Financing, Organized | 1 | 2020 | 202 | 0.040 |
Why?
|
| Focus Groups | 1 | 2023 | 1321 | 0.040 |
Why?
|
| Urban Population | 1 | 2006 | 2021 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2019 | 40561 | 0.040 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2005 | 1035 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 1 | 2003 | 933 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2020 | 977 | 0.040 |
Why?
|
| Sex Offenses | 1 | 2021 | 354 | 0.040 |
Why?
|
| Confidentiality | 1 | 2001 | 612 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2006 | 2278 | 0.030 |
Why?
|
| Community Health Services | 1 | 2001 | 650 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2006 | 6459 | 0.030 |
Why?
|
| Self Report | 2 | 2017 | 3558 | 0.030 |
Why?
|
| Emigration and Immigration | 1 | 1998 | 404 | 0.030 |
Why?
|
| Latin America | 1 | 2016 | 381 | 0.030 |
Why?
|
| Health Resources | 1 | 2001 | 911 | 0.030 |
Why?
|
| Comorbidity | 2 | 2021 | 10388 | 0.030 |
Why?
|
| Asia | 1 | 2016 | 610 | 0.030 |
Why?
|
| Growth | 1 | 2016 | 376 | 0.030 |
Why?
|
| Medically Uninsured | 1 | 2020 | 853 | 0.030 |
Why?
|
| Education | 1 | 2016 | 543 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2007 | 12026 | 0.030 |
Why?
|
| Cuba | 1 | 2012 | 47 | 0.030 |
Why?
|
| Minority Groups | 1 | 2020 | 1223 | 0.030 |
Why?
|
| Child Mortality | 1 | 2014 | 198 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2006 | 4371 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 13989 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14722 | 0.020 |
Why?
|
| Disease Progression | 1 | 2007 | 13284 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2017 | 1953 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 19905 | 0.020 |
Why?
|
| Mental Health Services | 1 | 2020 | 1643 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2017 | 2682 | 0.020 |
Why?
|
| Psychotherapy | 1 | 2017 | 1643 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2014 | 77449 | 0.020 |
Why?
|
| Psychometrics | 1 | 1997 | 3002 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2006 | 23338 | 0.020 |
Why?
|
| Incidence | 3 | 2004 | 20947 | 0.020 |
Why?
|
| Suicide | 1 | 2016 | 1477 | 0.020 |
Why?
|
| Perception | 1 | 2012 | 1198 | 0.020 |
Why?
|
| World Health Organization | 1 | 2010 | 1318 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2012 | 1425 | 0.020 |
Why?
|
| Netherlands | 1 | 2008 | 2170 | 0.010 |
Why?
|
| Directly Observed Therapy | 1 | 2004 | 137 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 1504 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2012 | 2418 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2007 | 1184 | 0.010 |
Why?
|
| Sputum | 1 | 2004 | 476 | 0.010 |
Why?
|
| Disease Notification | 1 | 2001 | 97 | 0.010 |
Why?
|
| Interview, Psychological | 1 | 2004 | 812 | 0.010 |
Why?
|
| National Health Programs | 1 | 2004 | 445 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2010 | 2266 | 0.010 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2004 | 567 | 0.010 |
Why?
|
| Contact Tracing | 1 | 2001 | 273 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2008 | 5078 | 0.010 |
Why?
|
| Medical Records | 1 | 2004 | 1413 | 0.010 |
Why?
|
| Time Factors | 2 | 2012 | 40075 | 0.010 |
Why?
|
| Aged | 3 | 2021 | 163280 | 0.010 |
Why?
|
| Probability | 1 | 2004 | 2505 | 0.010 |
Why?
|
| Age Distribution | 1 | 2004 | 2902 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 2886 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2004 | 1462 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2004 | 2618 | 0.010 |
Why?
|
| Pain | 1 | 2012 | 4986 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 57776 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 4933 | 0.010 |
Why?
|
| United States | 2 | 2020 | 69872 | 0.010 |
Why?
|
| Communicable Disease Control | 1 | 2001 | 857 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 6489 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2004 | 2684 | 0.010 |
Why?
|
| Logistic Models | 1 | 2008 | 13408 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10943 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1998 | 6365 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2001 | 5391 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 15076 | 0.000 |
Why?
|